Literature DB >> 1370163

Insulin-like growth factor-binding protein-3 is functionally normal in pregnancy serum.

A M Suikkari1, R C Baxter.   

Abstract

Insulin-like growth factor-binding protein-3 (IGFBP-3) carries most of the serum IGFs as a 150K ternary complex which increases during pregnancy. However, recent studies have demonstrated that IGFBP-3 is absent in pregnancy serum when measured by ligand blotting after electrophoresis. In the present study we demonstrate that, by several criteria, IGFBP-3 appears functionally intact in pregnancy serum. Serum samples were collected from pregnant women between 2-40 weeks gestation. Serum immunoreactive IGFBP-3 and acid-labile (alpha) subunit increased linearly throughout pregnancy. Ligand blotting confirmed diminution of IGFBP-3 at 2 weeks gestation and complete absence after 4 weeks gestation or when nonpregnancy serum was preincubated with amniotic fluid. When less harsh methods (neutral chromatography or transient acidification) were used, IGFBP-3 appeared functionally normal in pregnancy serum. Fractionation of pregnancy serum by Superose-12 gel permeation chromatography showed similar elution profiles for both IGFBP-3 and alpha-subunit compared to those for nonpregnancy serum. Preincubation of nonpregnancy serum with pregnancy serum or amniotic fluid had no effect on IGFBP-3 recovery. After acidification and neutralization of serum to destroy endogenous alpha-subunit, ternary complex formation, measured by radiolabeled alpha-subunit binding, was essentially identical in all nonpregnancy and pregnancy serum, except for a slight loss of activity in first trimester serum. Since the 150K complex cannot form unless IGFBP-3 binds IGFs and alpha-subunit normally, these results suggest that IGFBP-3 in native pregnancy serum is functionally normal.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1370163     DOI: 10.1210/jcem.74.1.1370163

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  8 in total

1.  Clinical and biochemical improvement in acromegaly during pregnancy.

Authors:  S L Lau; S McGrath; D Evain-Brion; R Smith
Journal:  J Endocrinol Invest       Date:  2008-03       Impact factor: 4.256

2.  Abnormal serum IGF-II transport in non-islet cell tumor hypoglycemia results from abnormalities of both IGF binding protein-3 and acid labile subunit and leads to elevation of serum free IGF-II.

Authors:  W H Daughaday; B Trivedi; R C Baxter
Journal:  Endocrine       Date:  1995-06       Impact factor: 3.633

3.  Serum "big insulin-like growth factor II" from patients with tumor hypoglycemia lacks normal E-domain O-linked glycosylation, a possible determinant of normal propeptide processing.

Authors:  W H Daughaday; B Trivedi; R C Baxter
Journal:  Proc Natl Acad Sci U S A       Date:  1993-06-15       Impact factor: 11.205

4.  Characterization of the binding defect in insulin-like growth factor binding protein-3 from pregnancy serum.

Authors:  R C Baxter; A M Suikkari; J L Martin
Journal:  Biochem J       Date:  1993-09-15       Impact factor: 3.857

5.  In vivo proteolysis of serum insulin-like growth factor (IGF) binding protein-3 results in increased availability of IGF to target cells.

Authors:  C Blat; J Villaudy; M Binoux
Journal:  J Clin Invest       Date:  1994-05       Impact factor: 14.808

6.  Insulin-like growth factor binding proteins: a structural perspective.

Authors:  Briony E Forbes; Peter McCarthy; Raymond S Norton
Journal:  Front Endocrinol (Lausanne)       Date:  2012-03-02       Impact factor: 5.555

7.  Sex Differences in Age-Related Decline of Urinary Insulin-Like Growth Factor-Binding Protein-3 Levels in Adult Bonobos and Chimpanzees.

Authors:  Verena Behringer; Stefan A Wudy; Werner F Blum; Jeroen M G Stevens; Thomas Remer; Christophe Boesch; Gottfried Hohmann
Journal:  Front Endocrinol (Lausanne)       Date:  2016-08-23       Impact factor: 5.555

8.  High-affinity recognition of specific tRNAs by an mRNA anticodon-binding groove.

Authors:  Krishna C Suddala; Jinwei Zhang
Journal:  Nat Struct Mol Biol       Date:  2019-12-02       Impact factor: 15.369

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.